Upgrade to SI Premium - Free Trial

AstraZeneca (AZN) PT Raised to $220 at Morgan Stanley

April 7, 2026 2:40 PM
Morgan Stanley analyst Sarita Kapila raised the price target on AstraZeneca (NASDAQ: AZN) to $220.00 (from $219.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change